weekly-nonogon-449910[.]framer[.]app

This domain, weekly-nonogon-449910.framer.app, is flagged as a generic phishing threat with an elevated risk level. Analysis indicates it is designed to deceive users into disclosing sensitive information through fake login portals or fraudulent web forms. The infrastructure exhibits no clear targeting of specific brands, suggesting a broader, opportunistic phishing campaign rather than a tailored impersonation effort. Infrastructure analysis reveals the following technical indicators: The domain resolves to IP address 35.71.142.77, hosted on infrastructure belonging to Amazon.com, Inc. (AS16509) in the United States. It uses a Let's Encrypt SSL certificate (identifier E7), which, while providing encryption, does not validate legitimacy. The domain was registered on February 21, 2026, through CSC Corporate Domains, Inc. Security vendors on VirusTotal flagged the domain, with 21 out of 95 detecting it as malicious. It appears on at least one security blocklist and was actively blocked by PhishDestroy prior to being taken offline. The page title, 'My Framer Site,' suggests an attempt to mimic a legitimate web development platform, potentially to exploit trust in the Framer brand. Mitigation measures should focus on preventing user interaction with this domain and similar threats. Network administrators are advised to implement DNS-based blocking for weekly-nonogon-449910.framer.app and monitor for connections to the associated IP address, 35.71.142.77. End-users should be educated on recognizing phishing indicators, such as mismatched URLs, generic page titles, and unsolicited requests for credentials. Organizations should enforce multi-factor authentication (MFA) to reduce the impact of credential theft. Security teams are encouraged to review logs for prior interactions with this domain and conduct retrospective analysis to identify any successful compromises. Given the domain's current offline status, continuous monitoring for reactivation or migration to new infrastructure is recommended.